Examining the Ease of Intubation Using the Parker Flex-Tip® or a Standard Endotracheal Tube
NCT ID: NCT01263873
Last Updated: 2014-12-17
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2010-11-30
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mallinckrodt (ETT)
Artifical Airway Device
Mallinckrodt (ETT)
7.0 millimeter internal diameter for female 8.0 millimeter internal diameter for male
Parker Flex Tip (ETT)
Artifical Airway Device
Parker Flex-Tip (ETT)
7.0 millimeter internal diameter for female 8.0 millimeter internal diameter for male
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mallinckrodt (ETT)
7.0 millimeter internal diameter for female 8.0 millimeter internal diameter for male
Parker Flex-Tip (ETT)
7.0 millimeter internal diameter for female 8.0 millimeter internal diameter for male
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Able to give informed consent (adults, English reading and speaking)
Exclusion Criteria
2. Any subject with an American Society of Anesthesiologist classification greater than 3.
3. Any subject needing rapid sequence induction.
4. Any subject that the anesthesia provider considers the GlideScope® to be contraindicated.
5. Any subject that an anesthesia provider feels for any reason at any time is not appropriate for inclusion in this study.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospitals Cleveland Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Brian Radesic
CRNA
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brian P Radesic, DNP, CRNA
Role: PRINCIPAL_INVESTIGATOR
University Hospitals Cleveland Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospitals of Cleveland
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Parker Flex tip endotracheal tube
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
04-10-05
Identifier Type: -
Identifier Source: org_study_id